
|Articles|October 15, 2018
Novotech and CNS Deal Expands CRO Services
Advertisement
Novotech, an Asia-Pacific-based CRO, has acquired Australasian specialist CRO Clinical Network Services (CNS) as part of a mission in hopes to expand services to biopharma for early phase product development and clinical research through to later phase regional and global trials.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
3
Is Artificial Intelligence Coming for Clinical Research?
4
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
5






.png)



.png)



.png)
.png)
